Free Trial

InnovAge (INNV) Competitors

InnovAge logo
$5.01 +0.03 (+0.60%)
Closing price 10/3/2025 04:00 PM Eastern
Extended Trading
$4.96 -0.04 (-0.90%)
As of 10/3/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

INNV vs. CON, VCYT, ADUS, CELC, LFST, GRAL, PACS, ARDT, NHC, and AVAH

Should you be buying InnovAge stock or one of its competitors? The main competitors of InnovAge include Concentra Group Holdings Parent (CON), Veracyte (VCYT), Addus HomeCare (ADUS), Celcuity (CELC), LifeStance Health Group (LFST), GRAIL (GRAL), PACS Group (PACS), Ardent Health (ARDT), National HealthCare (NHC), and Aveanna Healthcare (AVAH). These companies are all part of the "healthcare" industry.

InnovAge vs. Its Competitors

Concentra Group Holdings Parent (NYSE:CON) and InnovAge (NASDAQ:INNV) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations.

Concentra Group Holdings Parent has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Comparatively, InnovAge has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500.

In the previous week, InnovAge had 1 more articles in the media than Concentra Group Holdings Parent. MarketBeat recorded 1 mentions for InnovAge and 0 mentions for Concentra Group Holdings Parent. Concentra Group Holdings Parent's average media sentiment score of 0.00 equaled InnovAge'saverage media sentiment score.

Company Overall Sentiment
Concentra Group Holdings Parent Neutral
InnovAge Neutral

Concentra Group Holdings Parent has a net margin of 7.44% compared to InnovAge's net margin of -3.55%. Concentra Group Holdings Parent's return on equity of 50.84% beat InnovAge's return on equity.

Company Net Margins Return on Equity Return on Assets
Concentra Group Holdings Parent7.44% 50.84% 5.89%
InnovAge -3.55%-12.02%-5.73%

Concentra Group Holdings Parent has higher revenue and earnings than InnovAge. InnovAge is trading at a lower price-to-earnings ratio than Concentra Group Holdings Parent, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concentra Group Holdings Parent$1.90B1.40$166.54M$1.1917.48
InnovAge$853.70M0.80-$30.31M-$0.23-21.78

Concentra Group Holdings Parent presently has a consensus price target of $27.75, indicating a potential upside of 33.43%. InnovAge has a consensus price target of $5.00, indicating a potential downside of 0.20%. Given Concentra Group Holdings Parent's stronger consensus rating and higher probable upside, analysts plainly believe Concentra Group Holdings Parent is more favorable than InnovAge.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Concentra Group Holdings Parent
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
InnovAge
2 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.33

12.3% of InnovAge shares are held by institutional investors. 6.6% of Concentra Group Holdings Parent shares are held by insiders. Comparatively, 1.4% of InnovAge shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Concentra Group Holdings Parent beats InnovAge on 13 of the 15 factors compared between the two stocks.

Get InnovAge News Delivered to You Automatically

Sign up to receive the latest news and ratings for INNV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INNV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INNV vs. The Competition

MetricInnovAgeMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$679.55M$8.23B$6.13B$10.58B
Dividend YieldN/A2.80%5.66%4.69%
P/E Ratio-21.7854.5865.2722.75
Price / Sales0.8041.47607.74132.59
Price / CashN/A23.0126.3031.09
Price / Book2.856.7612.536.57
Net Income-$30.31M$250.93M$3.30B$276.78M
7 Day Performance4.38%2.29%4.28%2.42%
1 Month Performance32.19%3.27%6.90%8.63%
1 Year Performance-8.91%10.51%70.54%31.60%

InnovAge Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INNV
InnovAge
0.2726 of 5 stars
$5.01
+0.6%
$5.00
-0.2%
-8.9%$679.55M$853.70M-21.782,440
CON
Concentra Group Holdings Parent
2.8872 of 5 stars
$20.82
+0.3%
$27.75
+33.3%
-0.8%$2.67B$1.90B17.5011,250
VCYT
Veracyte
3.3503 of 5 stars
$33.91
+0.9%
$40.90
+20.6%
+9.6%$2.67B$445.76M102.81790
ADUS
Addus HomeCare
4.9635 of 5 stars
$119.06
+1.1%
$138.89
+16.7%
-9.1%$2.19B$1.15B26.2849,703News Coverage
Positive News
CELC
Celcuity
2.1501 of 5 stars
$49.95
-4.1%
$56.50
+13.1%
+235.8%$2.11BN/A-14.4440Analyst Forecast
LFST
LifeStance Health Group
2.6457 of 5 stars
$5.42
-0.1%
$8.50
+57.0%
-20.3%$2.11B$1.32B-108.3010,218
GRAL
GRAIL
1.2146 of 5 stars
$58.36
-0.7%
$31.50
-46.0%
+403.0%$2.10B$125.60M-4.441,360News Coverage
Positive News
Analyst Forecast
Insider Trade
PACS
PACS Group
3.0855 of 5 stars
$13.36
-3.3%
$31.00
+132.0%
-64.4%$2.04B$3.11B0.0032,433Upcoming Earnings
ARDT
Ardent Health
3.945 of 5 stars
$13.42
+1.1%
$19.33
+44.0%
-22.3%$1.92B$5.97B7.4124,900Gap Up
NHC
National HealthCare
N/A$120.98
-0.7%
N/A-1.4%$1.88B$1.46B15.1612,400Positive News
Ex-Dividend
AVAH
Aveanna Healthcare
0.974 of 5 stars
$8.83
-0.4%
$7.92
-10.4%
+90.5%$1.85B$2.02B110.7633,500

Related Companies and Tools


This page (NASDAQ:INNV) was last updated on 10/5/2025 by MarketBeat.com Staff
From Our Partners